UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
43.62
-1.88 (-4.13%)
At close: Aug 28, 2026, 4:00 PM EDT
44.98
+1.36 (3.12%)
After-hours: Aug 28, 2026, 7:59 PM EDT
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $2.13 billion as of August 28, 2026. Its market cap has increased by 135.86% in one year.
Market Cap
2.13B
Enterprise Value
2.22B
1-Year Change
135.86%
Ranking
Category
Stock Price
$43.62
ChartMarket Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $2.13B, an increase of 1,072.17%. That is a compound annual growth rate of 30.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 2.13B | 94.49% |
| Dec 31, 2025 | 1.10B | 143.95% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
| May 4, 2017 | 181.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Harmony Biosciences Holdings | 2.32B |
| Hemab Therapeutics Holdings | 2.31B |
| Mineralys Therapeutics | 2.30B |
| Sarepta Therapeutics | 2.28B |
| Nanobiotix | 2.28B |
| Mesoblast | 2.25B |
| Aurinia Pharmaceuticals | 2.19B |
| Maravai LifeSciences Holdings | 2.17B |